Elisa Petris
InvestorManaging Partner, Syncona Investment Management Limited at Syncona · Office Manager at Red Dot Capital Partners
London, England, United Kingdom
Find your path to Elisa
360 people in our graph share verified history with Elisa — schools, employers, funds. One of them is your warm intro.
About
Elisa Petris is a Managing Partner at Syncona Investment Management Limited and a member of the firm's founding team, with over a decade of experience building its portfolio of life science companies. She has helped establish companies including Quell, Blue Earth, Achilles, and Beacon, serving as Chief Business Officer at Beacon during its early period. Before Syncona she was a Senior Associate at Michel Dyens & Co. and worked on the Life Sciences team at L.E.K. Consulting; she holds a PhD in Molecular Biology from Imperial College London and an MBA from London Business School.
Invests in
BiotechHealthtechMedical Devices
Experience
- Syncona LimitedManaging Partnercurrent2025 — present
- Syncona LimitedPartner2013 — 2025London, United Kingdom
- Invest In EquityCo-Founder & Board Directorcurrent2025 — presentLondon Area, United Kingdom
- Forcefield TherapeuticsExecutive Chaircurrent2026 — presentLondon, England, United Kingdom
- Forcefield TherapeuticsNon Executive Director2023 — 2026
- Beacon TherapeuticsNon Executive Directorcurrent2022 — present
- Beacon TherapeuticsInterim Head BD & Alliances2022 — 2024
- Quell TherapeuticsNon Executive Directorcurrent2019 — presentLondon, United Kingdom
- Achilles Therapeutics LimitedNon Executive Director2018 — 2019
- Achilles Therapeutics LimitedBoard Observer2016 — 2018
- Blue Earth DiagnosticsNon Executive Director2018 — 2019
- Blue Earth DiagnosticsBoard Observer2014 — 2018
- London Business SchoolMBA2011 — 2013
- Syncona PartnersPartner2013
- AmgenMBA Summer Intern2012
- Michel Dyens & Co.Healthcare Senior Associate2009 — 2011
- L.E.K. ConsultingSenior Associate Consultant2005 — 2009
Skills & more
From Elisa's professional profile.
Deals · 1
Neogene TherapeuticsBoard seat
via Syncona · filed Sep 2020 · $110M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
31 Quell TherapeuticsAchilles TherapeuticsBeacon TherapeuticsBlue Earth DiagnosticsForcefield Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Syncona
Frequently asked questions
- Who is Elisa Petris?
- Elisa Petris is a Managing Partner at Syncona Investment Management Limited and a member of the firm's founding team, with over a decade of experience building its portfolio of life science companies. She has helped establish companies including Quell, Blue Earth, Achilles, and Beacon, serving as Chief Business Officer at Beacon during its early period. Before Syncona she was a Senior Associate at Michel Dyens & Co. and worked on the Life Sciences team at L.E.K. Consulting; she holds a PhD in Molecular Biology from Imperial College London and an MBA from London Business School.
- Where does Elisa Petris work?
- Elisa Petris is Managing Partner, Syncona Investment Management Limited at Syncona.
- What does Elisa Petris invest in?
- Elisa Petris invests in Biotech, Healthtech, Medical Devices.
- What boards does Elisa Petris sit on?
- Elisa Petris holds tracked board seats at 31 Quell Therapeutics, Achilles Therapeutics, Beacon Therapeutics, Blue Earth Diagnostics, Forcefield Therapeutics, Neogene Therapeutics, Neogene Therapeutics.
- Where did Elisa Petris go to school?
- Elisa Petris studied at London Business School (MBA); Imperial College London (PhD, Molecular Biology); Imperial College London (BSc, Biology).
Same school
Also attended London Business School911
+ 905 more
Shared employers
Also worked at Syncona Limited21
+ 15 more
Also worked at Invest In Equity2
Also worked at Quell Therapeutics9
+ 3 more
